Patents by Inventor Joseph E. De Larco

Joseph E. De Larco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor egress factor and processes for producing the same
    Patent number: 5039794
    Abstract: A novel cell scattering factor, i.e., tumor egress factor (hereinafter "egressin") isolated from a clone derived from a human metastatic melanoma (M3827) which possesses a loose colony morphology and from a human monocytic cell line (U937) and processes for producing the same. Egressin is useful for the production of immunological reagents for the detection and treatment of metastatic lesions, for aiding in the transport of drugs across the blood-brain barrier, and for aiding in the control of the inflammatory response.
    Type: Grant
    Filed: September 15, 1987
    Date of Patent: August 13, 1991
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Marjorie L. Wier, Joseph E. De Larco